Moxifloxacin
Anti-infective · Rx
RxAnti-infectiveAntibioticPreservative-free option Tan cap
| Strength | 0.5% |
|---|---|
| Typical quantity | 3 mL bottle (generic available) |
| Cash cost / month | Low · ~$0-20 |
| Drug class | Antibiotic, 4th-gen fluoroquinolone |
| Mechanism of action | Inhibits bacterial DNA gyrase and topoisomerase IV; broad Gram-positive, Gram-negative and some atypical coverage. Self-preserved (no added BAK). |
| Indication / reason for use | Bacterial conjunctivitis; empiric therapy and surgical prophylaxis; adjunct for low-risk bacterial keratitis. |
| Usual adult dosing | Bacterial conjunctivitis: 1 drop TID (Vigamox) or BID (Moxeza) for 7 days. Keratitis: much more frequent, per severity. |
| Preservative | Preservative-free (self-preserving) , a preservative-free option exists |
| Contact lenses | Do not wear contact lenses while you have signs/symptoms of bacterial conjunctivitis or during keratitis treatment. |
| Common / important adverse effects | Conjunctival irritation, dry eye, dysgeusia; rare hypersensitivity. |
| Contraindications & cautions | Fluoroquinolone hypersensitivity. |
| Pregnancy / lactation | Limited data; topical exposure low. Systemic fluoroquinolone tendon warnings are not established for ophthalmic use. |
| Pregnancy category (older labels) | No letter category on the current label. From DailyMed labels, checked Nov 2026. |
| Trade names | Vigamox 0.5%, Moxeza 0.5% |
| Practice notes | For a central ulcer or contact-lens-related keratitis, refer for cultures and fortified antibiotics rather than treating empirically. |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.